Waisman Biomanufacturing

Exhibitor

Waisman Biomanufacturing is a cGMP facility with comprehensive experience in providing contracting manufacturing services including the clinical production of vaccines, gene therapeutics, cell therapeutics, and recombinant proteins for Phase I and Phase II clinical trials.  Our process development and manufacturing teams have developed platform manufacturing processes and analytical methods to support the production of adenoviral vectors, AAV, lentiviral vectors, plasmid DNA, MSCs, pluripotent stem cells (hESCs, iPSCs), and differentiated cells. WB provides full Chemistry, Manufacturing, and Control (CMC) support for Investigational New Drug (IND) filings. We work closely with clients at every step to tailor each project to their needs.

website